Hematopoietic stem cell transplantation in children and adolescents with nonremission acute lymphoblastic leukemia.

Yasuhiro Okamoto Yozo NakazawaMasami InoueKenichiro WatanabeHiroaki GotoNao YoshidaMaiko NoguchiAtsushi KikutaKoji KatoYoshiko HashiiYoshiko AtsutaMotohiro Kato

Published in: Pediatric blood & cancer (2020)

These results support HSCT in certain nonremission patients. Even in patients without complete remission, outcomes differed according to pre-HSCT factors. A scoring system could help determine the appropriateness of HSCT in children and adolescents with nonremission ALL.

Keyphrases

end stage renal disease
acute lymphoblastic leukemia
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
type diabetes
systemic lupus erythematosus
allogeneic hematopoietic stem cell transplantation